|
|
Post by fldave007 on Apr 4, 2019 8:18:27 GMT -5
For to long Mnkd has been thinking inside the box and thus far it has been a resounding failure. The commercials and advertisements have been completely ineffective to date. We can't advertise like big established pharmaceutical companies and expect to be competitive. Were small and should be able to turn on a dime when we see something is not working. We all know that afrezza works and works better than most every other insulin when used correctly. The point of the commercials should have always been no needles, highlighting that simple fact. The stupid ad Mnkd uses is lame, I don't care if it won some stupid ass awards it is not good simple as that. I can think of a million better ways to reach the consumer. How about a simple shot of two people one injecting and one inhaling insulin with the words which would you rather do? Come on a commercial has a limited time to grab your attention do something else I don't care how much it costs just do a different commercial and don't let the ad agency keep you from doing the type of commercial you want. Partner up with VDEX in a big way people need to know how to titrate correctly right away and if they don't they will quit taking afrezza. Magazine ads need to be exploited to better effect and more hard hitting keep it simple stupid should be our manifesto, again highlighting the fact of no needles and better control. What I'm trying to say there are a million things we could be doing better and we need to start now.
|
|
|
|
Post by sportsrancho on Apr 4, 2019 8:55:12 GMT -5
Amen!
|
|
|
|
Post by lojothehus on Apr 4, 2019 9:53:40 GMT -5
Fldave007, you have said it all! Maybe they should hire you and fly you around the world and fire everyone else, that would save the company some money. MNKD will never beat big pharmaceuticals playing by their rules. I have been saying this for some years now, MAKE SOME NOISE! NO NEEDLES, BETTER A1C's! Create a buzz, Dreamboat key chains; Dreamboat Cell phone cases; Dreamboat necklaces; Fighting diabetes has just gotten easier!
|
|
|
|
Post by sweedee79 on Apr 4, 2019 11:22:54 GMT -5
You make some very good points..
But ever since I heard that rumor that Vdex was seeking control of Afrezza for royalties I have not trusted them.. I don't care for someone trying to get Afrezza for cheap . Seems unscrupulous to me..
I think it's a good idea to partner with Vdex if the terms are right, but certainly not give it to them.. they don't have the capital to market Afrezza any better than we do.. and royalties from 200 patients on Afrezza isn't much.
Mnkd would need to have a good relationship with Vdex in order to partner in some way. I question whether they do have a good relationship from things I've heard.
As far as partners go.. first we need a partner. And I'm not sure that our prospects have been good for an Afrezza partner or we would have one already.
|
|
|
|
Post by sportsrancho on Apr 4, 2019 11:55:55 GMT -5
Rumors or assumptions about capital aside, there’s a lot to learn from Vdex because they have the retention, the correct dosing. They approach Afrezza the way Al did. There is no one I trust more..if I had a close friend that was a diabetic I would drive them to the nearest clinic. I certainly wouldn’t send them off to try and talk their Endo into it. That could take months and a lot of frustration.
Well that was insensitive. I didn’t mean it to be, there aren’t enough clinics so you have to go to your Endo and I salute Rick for all the hard work he did getting his friend a script!
|
|
|
|
Post by buyitonsale on Apr 4, 2019 12:02:10 GMT -5
There are about 60 doctors listed on Afrezza website in Los Angeles area, second largest market in USA.
Each one probably only prescribes to 1 or 2 patients.
People seeing a commercial cannot do anything without a script.
Doctors are a bottleneck.
MNKD needs to figure out how to work with doctors better.
Sorry to say, but CMO is not helping in that area yet.
Al signed with Sanofi because they would be able to influence doctors to prescribe, as they had a blockbuster basal insulin already and Apidra was not really competitive... Unfortunately there was a change of direction and Sanofi sabotaged the launch.
Solve the doctor riddle Mike!
|
|
|
|
Post by sweedee79 on Apr 4, 2019 12:14:19 GMT -5
We need a big pharma partner .. with deep pockets . It doesn't appear that Vdex has that..
And I agree that Vdex has done well with prescribing the drug in an appropriate manner and have had good results.. but that doesn't make them a good partner..
From what Vdex has stated on this board they too are having the same problems with insurance and providers as we are. So how does that make them a good partner?
The question is can Vdex market the drug and overcome the hurdles any better than we can? How does partnering with Vdex help MNKD?
If a deal was presented that was beneficial to Mnkd I am open minded.. I just don't see it.. JMHO
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Apr 4, 2019 12:27:27 GMT -5
For to long Mnkd has been thinking inside the box and thus far it has been a resounding failure. The commercials and advertisements have been completely ineffective to date. We can't advertise like big established pharmaceutical companies and expect to be competitive. Were small and should be able to turn on a dime when we see something is not working. We all know that afrezza works and works better than most every other insulin when used correctly. The point of the commercials should have always been no needles, highlighting that simple fact. The stupid ad Mnkd uses is lame, I don't care if it won some stupid ass awards it is not good simple as that. I can think of a million better ways to reach the consumer. How about a simple shot of two people one injecting and one inhaling insulin with the words which would you rather do? Come on a commercial has a limited time to grab your attention do something else I don't care how much it costs just do a different commercial and don't let the ad agency keep you from doing the type of commercial you want. Partner up with VDEX in a big way people need to know how to titrate correctly right away and if they don't they will quit taking afrezza. Magazine ads need to be exploited to better effect and more hard hitting keep it simple stupid should be our manifesto, again highlighting the fact of no needles and better control. What I'm trying to say there are a million things we could be doing better and we need to start now. You sound like a frustrated dude who made a bad decision in buying MNKD Stock. OWN IT...... You have ALL THE ANSWERS!!!! Why don't you become a CEO of a Pharmaceutical company and see how easy it is. |
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Apr 4, 2019 12:31:19 GMT -5
Rumors or assumptions about capital aside, there’s a lot to learn from Vdex because they have the retention, the correct dosing. They approach Afrezza the way Al did. There is no one I trust more..if I had a close friend that was a diabetic I would drive them to the nearest clinic. I certainly wouldn’t send them off to try and talk their Endo into it. That could take months and a lot of frustration. Well that was insensitive. I didn’t mean it to be, there aren’t enough clinics so you have to go to your Endo and I salute Rick for all the hard work he did getting his friend a script! That's all well and good but VDEX is not a pharmaceutical company. They don't have the same restrictions as MNKD. Their business model will not work at MNKD. Mike has laid out the road map and has set expectations. Everyone wants the stock price higher yesterday. Well it doesn't work that way. There's a lot of groundwork going on behind the scenes and it will take time to rollout. |
|
|
|
Post by lifebreath on Apr 4, 2019 12:48:29 GMT -5
I introduced a friend who has been a type 1 for 40 years. He chronically suffers from low blood sugar episodes. Reading all the information about Afrezza he decided to try it. It took a great deal of persistence to get the prescription the endo told him patients were having problems with coughing.
He started using it and no more lows, but he to suffered from coughing after inhaling, so he quit using it. I read here on pro boards that someone advised a slow inhalation method. I told my friend to try using it again and inhale slowly. He is back on Afrezza very happy with it and no more coughing.
He had no advise from the endo and followed the instruction that came with Afrezza, perhaps mnkd should revise the instructions to have a little more detail on tritation
|
|
|
|
Post by tw12 on Apr 4, 2019 14:26:03 GMT -5
I agree on the urgent need for more creative and memorable messaging. Make the ads simple, direct and keyed to the distinguishing features of Afrezza.
My contribution, years ago, was "The Inspired Insulin," simply showing people inhaling happily (and slowly!) in different public settings. I even trademarked the phrase to protect it for MannKind's use and also met personally with the head of their ad agency in Boston but no one was interested...
Someone else has suggested "The Pocket Pancreas." Perfect!
|
|
|
|
Post by mytakeonit on Apr 4, 2019 14:32:47 GMT -5
Rumors or assumptions about capital aside, there’s a lot to learn from Vdex because they have the retention, the correct dosing. They approach Afrezza the way Al did. There is no one I trust more..if I had a close friend that was a diabetic I would drive them to the nearest clinic. I certainly wouldn’t send them off to try and talk their Endo into it. That could take months and a lot of frustration. Well that was insensitive. I didn’t mean it to be, there aren’t enough clinics so you have to go to your Endo and I salute Rick for all the hard work he did getting his friend a script! I say drive them to the nearest clinic. Insensitivity can be cured with a glass of red wine. And the ad we should use ... is that same 97 years of insulin poster ... with the dreamboat angled in the empty space. But, that's mytakeonit |
|
|
|
Post by sportsrancho on Apr 4, 2019 14:39:12 GMT -5
OK the scoop on the ad is they can’t put the name of the drug on there because then they have to follow with FDA warnings. It’s called an unbranded ad.
|
|
|
|
Post by prcgorman2 on Apr 4, 2019 14:41:17 GMT -5
I introduced a friend who has been a type 1 for 40 years. He chronically suffers from low blood sugar episodes. Reading all the information about Afrezza he decided to try it. It took a great deal of persistence to get the prescription the endo told him patients were having problems with coughing. He started using it and no more lows, but he to suffered from coughing after inhaling, so he quit using it. I read here on pro boards that someone advised a slow inhalation method. I told my friend to try using it again and inhale slowly. He is back on Afrezza very happy with it and no more coughing. He had no advise from the endo and followed the instruction that came with Afrezza, perhaps mnkd should revise the instructions to have a little more detail on tritation There was a Canadian ENT doctor (I think) that posted a few years ago that taking a sip of water before inhaling might help with coughing too. He had some other suggestions but I only remembered the sip of water. :-( |
|
|
|
Post by lifebreath on Apr 4, 2019 14:46:09 GMT -5
Anyone remember the picture Mike tweeted in 2016! Of the little girl with hundreds of needles sticking into her?
|
|
